Nov 9, 2021
In this episode, Dr. Jeffrey Strawn
addresses your unanswered questions from his presentation:
Re-Counting Neurobiological Treatment Advances of
Obsessive-Compulsive Disorder.
Dr. Jeffrey R. Strawn's early work
examined the neurophysiology, neurochemistry and neuroanatomy of
anxiety disorders in children and adolescents.In parallel with Dr.
Strawn's work on the neurophysiology of mood and anxiety disorders
in children and adolescents, he has worked to increase the evidence
base for treatment interventions in youth. Using meta-analysis, he
demonstrated that antidepressants are well-tolerated in pediatric
patients with anxiety disorders, but also examined specific
class-specific side effects (e.g., activation). Also, he has
examined the unique tolerability of antidepressants in special
populations of adolescents with depressive and anxiety disorders
(e.g., those who are at high risk for the development of bipolar
disorder) and has observed that antidepressants are poorly
tolerated in this population with likelihood of antidepressant
adverse events leading to discontinuation being directly related to
age. Additionally, he has extensive expertise in the conduct of
double blind, placebo-controlled trials in youth with anxiety
disorders.